NIH’s new Rapid Acceleration of Diagnostics initiative, or RADx Tech, aims to bring accurate, rapid, and easy-to-use COVID diagnostic tests to all Americans. Learn how NIBIB’s Point of Care network has mobilized engineers and innovators across the country to create different types of tests for use in a variety of settings and communities to help overcome this global crisis.
News & Events
Share:
Latest News & Highlights
The National Institutes of Health has launched an ambitious effort to use artificial intelligence, computation, and medical imaging to enable early disease detection, inform successful treatment strategies, and predict individual disease outcomes of COVID-19.
NIH is investing $248.7 million in new technologies to address challenges associated with COVID-19 testing (which detects SARS-CoV-2 coronavirus). NIH’s RADx initiative has awarded contracts to seven biomedical diagnostic companies to support a range of new lab-based and point-of-care tests.
In a paper in the New England Journal of Medicine, scientific leaders from the National Institutes of Health set forth a framework to increase significantly the number, quality and type of daily tests for detecting SARS-CoV-2, the virus that causes COVID-19, and help reduce inequities for…
17th International Conference on Methods and Applications in Fluorescence
Sunday, September 06, 2020 to Wednesday, September 09, 2020
Gotenburg, Sweden